{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T03:32:33Z","timestamp":1675567953611},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T00:00:00Z","timestamp":1308873600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s00228-011-1085-5","type":"journal-article","created":{"date-parts":[[2011,6,23]],"date-time":"2011-06-23T08:14:48Z","timestamp":1308816888000},"page":"1313-1314","source":"Crossref","is-referenced-by-count":2,"title":["Ivabradine and nightmares: a previously unreported adverse reaction"],"prefix":"10.1007","volume":"67","author":[{"given":"Knut Tore","family":"Lappeg\u00e5rd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabet","family":"Nordmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,24]]},"reference":[{"key":"1085_CR1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00002018-200831020-00001","volume":"31","author":"I Savelieva","year":"2008","unstructured":"Savelieva I, Camm AJ (2008) If inhibition with ivabradine: electrophysiological effects and safety. Drug Saf 31:95\u2013107","journal-title":"Drug Saf"},{"key":"1085_CR2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000095430","volume":"43","author":"I Savelieva","year":"2006","unstructured":"Savelieva I, Camm AJ (2006) Novel If current inhibitor ivabradine: safety considerations. Adv Cardiol 43:79\u201396","journal-title":"Adv Cardiol"},{"key":"1085_CR3","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","volume":"372","author":"K Fox","year":"2008","unstructured":"Fox K, Ford I, Steg PG, Tendera M, Ferrari R, Investigators BEAUTIFUL (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372:807\u2013816","journal-title":"Lancet"},{"key":"1085_CR4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","volume":"376","author":"K Swedberg","year":"2010","unstructured":"Swedberg K, Komajda M, B\u00f6hm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L, Investigators SHIFT (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376:875\u2013885","journal-title":"Lancet"},{"key":"1085_CR5","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(10)61259-7","volume":"376","author":"M B\u00f6hm","year":"2010","unstructured":"B\u00f6hm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L, SHIFT Investigators (2010) Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 376:886\u2013894","journal-title":"Lancet"},{"key":"1085_CR6","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1111\/j.1540-8159.2009.02587.x","volume":"33","author":"L Capulzini","year":"2010","unstructured":"Capulzini L, Sarkozy A, Semeraro O, Paparella G, Chierchia GB, de Asmundis C, Roos M, Yazaki Y, Muller-Burri A, Sorgente A, Brugada P (2010) Ivabradine to treat inappropriate sinus tachycardia after the fast pathway ablation in a patient with severe pectus excavatum. Pacing Clin Electrophysiol 33:e32\u2013e35","journal-title":"Pacing Clin Electrophysiol"},{"key":"1085_CR7","first-page":"166","volume":"17","author":"E Kaplinsky","year":"2010","unstructured":"Kaplinsky E, Comes FP, Urondo LS, Ayma FP (2010) Efficacy of ivabradine in four patients with inappropriate sinus tachycardia: a three month-long experience based on electrocardiographic, Holter monitoring, exercise tolerance and quality of life assessments. Cardiol J 17:166\u2013171","journal-title":"Cardiol J"},{"key":"1085_CR8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1540-8159.2009.02186.x","volume":"32","author":"S Khan","year":"2009","unstructured":"Khan S, Hamid S, Rinaldi C (2009) Treatment of inappropriate sinus tachycardia with ivabradine in a patient with postural orthostatic tachycardia syndrome and a dual chamber pacemaker. Pacing Clin Electrophysiol 32:131\u2013133","journal-title":"Pacing Clin Electrophysiol"},{"key":"1085_CR9","first-page":"935","volume":"68","author":"OO Celebi","year":"2010","unstructured":"Celebi OO, Canbay A, Celebi S, Aydogdu S, Diker E (2010) Inappropriate sinus tachycardia\u2014successful treatment with ivabradine. Kardiol Pol 68:935\u2013937","journal-title":"Kardiol Pol"},{"key":"1085_CR10","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1540-8159.2009.02414.x","volume":"32","author":"PF Winum","year":"2009","unstructured":"Winum PF, Cayla G, Rubini M, Beck L, Messner-Pellenc P (2009) A case of cardiomyopathy induced by inappropriate sinus tachycardia and cured by ivabradine. Pacing Clin Electrophysiol 32:942\u2013944","journal-title":"Pacing Clin Electrophysiol"},{"key":"1085_CR11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/europace\/euq390","volume":"13","author":"C McDonald","year":"2011","unstructured":"McDonald C, Frith J, Newton JL (2011) Single centre experience of ivabradine in postural orthostatic tachycardia syndrome. Europace 13:427\u2013430","journal-title":"Europace"},{"key":"1085_CR12","unstructured":"European Medicines Agency. Corlentor: EPAR\u2014scientific discussion. www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Scientific_Discussion\/human\/000598\/WC500035338.pdf , published: 4 November 2005"},{"key":"1085_CR13","first-page":"1","volume":"3","author":"G Marquis-Gravel","year":"2008","unstructured":"Marquis-Gravel G, Tardif JC (2008) Ivabradine: the evidence of its therapeutic impact in angina. Core Evid 3:1\u201312","journal-title":"Core Evid"},{"key":"1085_CR14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/hup.465","volume":"18","author":"JF Pagel","year":"2003","unstructured":"Pagel JF, Helfter P (2003) Drug induced nightmares\u2014an etiology based review. Hum Psychopharmacol 18:59\u201367","journal-title":"Hum Psychopharmacol"},{"key":"1085_CR15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0163-7258(90)90092-G","volume":"46","author":"J McAinsh","year":"1990","unstructured":"McAinsh J, Cruickshank JM (1990) Beta-blockers and central nervous system side effects. Pharmacol Ther 46:163\u2013197","journal-title":"Pharmacol Ther"},{"key":"1085_CR16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239\u2013245","journal-title":"Clin Pharmacol Ther"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-011-1085-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-011-1085-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-011-1085-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T08:48:52Z","timestamp":1558687732000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-011-1085-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,24]]},"references-count":16,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1085"],"URL":"https:\/\/doi.org\/10.1007\/s00228-011-1085-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,24]]}}}